​

Surrozen (SRZN) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Surrozen Revenue Highlights

Latest Revenue (Y)

$10.65M

Latest Revenue (Q)

$655.00K

Main Segment (Y)

Collaboration and license revenue

Main Geography (Y)

GERMANY

Surrozen Revenue by Period

Surrozen Revenue by Year

DateRevenueChange
2024-12-31$10.65M100.00%
2023-12-31--100.00%
2022-12-31$12.50M100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31--

Surrozen generated $10.65M in revenue during NA 2024, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Surrozen Revenue by Quarter

DateRevenueChange
2024-12-31$655.00K-93.45%
2024-09-30$10.00M100.00%
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$4.15M100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31--100.00%
2022-12-31$12.50M100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31--

Surrozen generated $655.00K in revenue during Q4 2024, up -93.45% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Surrozen Revenue Breakdown

Surrozen Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24
Collaboration and license revenue$10.00M

Surrozen's latest annual revenue breakdown by segment (product or service), as of Dec 24: Collaboration and license revenue (100.00%).

Surrozen Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 24
GERMANY$10.00M
UNITED STATES$700.00K

Surrozen's latest annual revenue breakdown by geography, as of Dec 24: GERMANY (93.46%), and UNITED STATES (6.54%).

Quarterly Revenue by Country

CountryMar 25
UNITED STATES$1.00M

Surrozen's latest quarterly revenue breakdown by geography, as of Mar 25: UNITED STATES (100.00%).

Surrozen Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
CTMXCytomX Therapeutics$138.10M$50.92M
GOSSGossamer Bio$114.70M$9.89M
SPROSpero Therapeutics$47.98M$9.36M
SRZNSurrozen$10.65M$655.00K
KRONKronos Bio$9.85M$2.27M
BOLTBolt Biotherapeutics$7.69M$1.22M
KROSKeros Therapeutics$3.55M$3.04M
LYRALyra Therapeutics$1.53M$209.00K
APMAptorum Group$431.38K-
REPLReplimune Group--
KZRKezar Life Sciences--
NVCTNuvectis Pharma--
TILInstil Bio--
ASMBAssembly Biosciences-$7.36M
PCSAProcessa Pharmaceuticals--
UNCYUnicycive Therapeutics--
TPSTTempest Therapeutics-$486.00K
LRMRLarimar Therapeutics--

SRZN Revenue FAQ

What is Surrozen’s yearly revenue?

Surrozen's yearly revenue for 2024 was $10.66M, representing an increase of 100.00% compared to 2023. The company's yearly revenue for 2023 was $0, representing a decrease of -100.00% compared to 2022. SRZN's yearly revenue for 2022 was $12.5M, representing an increase of 100.00% compared to 2021.

What is Surrozen’s quarterly revenue?

Surrozen's quarterly revenue for Q4 2024 was $655K, a -93.45% decrease from the previous quarter (Q3 2024), and a -84.20% decrease year-over-year (Q4 2023). The company's quarterly revenue for Q3 2024 was $10M, a 100.00% increase from the previous quarter (Q2 2024), and a 0% increase year-over-year (Q3 2023). SRZN's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023).

What is Surrozen’s revenue growth rate?

Surrozen's revenue growth rate for the last 3 years (2022-2024) was -14.76%, and for the last 5 years (2020-2024) was 0%.

What are Surrozen’s revenue streams?

Surrozen's revenue streams in c 24 are Collaboration and license revenue

What is Surrozen’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Surrozen was Collaboration and license revenue. This segment made a revenue of $10M, representing 100.00% of the company's total revenue.